OBA Safety Symposium Sept 2004 resources


	Resources

	General Biosafety Guidance NIH Guidelines for Research Involving Recombinant DNA Molecules Biosafety in Microbiological and Biomedical Laboratories 4th edition USDA ARS CSREES ERS NASS Manual- Chapter 9.4.4 Biosafety Level 3 Agriculture (BSL-3Ag) World Health Organization Laboratory Biosafety Manual 3rd edition Health Canada Material Safety Data Sheets American Biological Safety Association American Industrial Hygiene Association

	Introduction to Risk Assessment Slides from Dr. E. Barkley’s presentation NIH Guidelines template

	Current Information and Biosafety Guidance for Wild Type Influenza viruses Sections from the NIH Guidelines Sections from the BMBL CDC Update on Avian Influenza A (H5N1) ( Aug. 12, 2004 ) Avian Influenza: USDA Permitting Requirements under 9 CFR 122 (L. A. Thomas presentation) USDA/CDC Select Agent Program: Data Necessary to Consider Select Agent Exclusion Requests Attentuated Strains of Highly Pathogenic Avian Influenza Viruses WHO laboratory biosafety guidelines for handling specimens suspected of containing highly pathogenic avian influenza A/H5 virus WHO Production of pilot lots of inactivated influenza vaccines from reassortants derived from avian influenza viruses Health Canada Biosafety Advisory Highly Pathogenic Avian Influenza United Kingdom Health and Safety Executive Advice on Assessing the Risks of Working with Highly Pathogenic Avian Influenza Virus Avian Influenza Virus Program at the Virginia-Maryland Regional College of Veterinary Medicine Interim CDC-NIH Recommendation for Raising the Biosafety Level for Laboratory Work Involving Noncontemporary Human Influenza (H2N2) Viruses (May 2005) Revisions to the influenza summary statement for the 5th edition of the BMBL (Dr. J Katz presentation at 6/2005 RAC meeting) Harmonization of the NIH Guidelines with other federal Guidances: Biological containment for work with noncontemporary strains of influenza (Dr. K. Harris presentation at 6/2005 RAC meeting)

	Current Biosafety Guidance for Wild Type SARS-CoV WHO biosafety Guidelines for handling of SARS specimens WHO post-outbreak biosafety guidelines for handling of SARS-CoV specimens and cultures WHO Alert, verification, and public health management of SARS in the post-outbreak period United Kingdom Health and Safety Advisory Severe acute respiratory syndrome (SARS)

	Examples of Risk Assessment Templates for pathogenic virus research Influenza viruses Recombinant influenza virus containment Coronaviruses

	Examples of Risk Assessments Slides from Dr. Y. Kawaoka’s presentation: H5N1 and 1918 influenza viruses Slides from Dr. A. Garcia-Sastre’s presentation: 1918 influenza virus Slide from Dr. R. Webster’s presentation: Containment for HPAI research Slides from Dr. R. Baric’s presentation: SARS-CoV

	Occupational Medical Services for Biomedical Research

	Recombinant Influenza virus and SARS-CoV references Tumpey, T., et al., (2004) Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus, PNAS 101:3166-3171. Webby, R., and R. Webster, (2003) Are we ready for pandemic influenza? Science 302:1519-1522. Enserink, M., (2004) Tiptoeing around Pandora’s box, Science 305: 594-595. Holmes, K., and L. Enjuanes, (2003) The SARS coronavirus: A postgenomic era Science 300: 1377-1378. Yount, B. et al., Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus PNAS 100:12995-13000.